SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Share News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.00    -0.25 (-2.04%)
Bid:
11.50
Ask:
12.50
Spread: 1.00 (8.696%)
Market Cap: £15.02m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Fusion Antibodies News

Fusion Antibodies drops as annual revenue seen significantly lower
6 Mar 2023

Fusion Antibodies drops as annual revenue seen significantly lower

(Alliance News) - Fusion Antibodies PLC on Monday said it expects annual revenue to be significantly below expectations as a result of continued uncer...

AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion
6 Mar 2023

AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

LONDON MARKET OPEN: Sluggish open ahead of US Fed testimony this week
6 Mar 2023

LONDON MARKET OPEN: Sluggish open ahead of US Fed testimony this week

(Alliance News) - London's equities got off to a slow start on Monday, lagging behind more positive trading in Europe and Friday's rally on Wall Stree...

Fusion Antibodies launches first commercial service from OptiMAL
9 Feb 2023

Fusion Antibodies launches first commercial service from OptiMAL

(Alliance News) - Fusion Antibodies PLC on Thursday celebrated the launch of a new commercial service from its research and development programme, des...

Fusion Antibodies confident after 'challenging' first half
5 Dec 2022

Fusion Antibodies confident after 'challenging' first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenues of £1.9m on Monday, down from £2.4m year-on...

Fusion Antibodies half-year loss doubles amid investment delays
5 Dec 2022

Fusion Antibodies half-year loss doubles amid investment delays

(Alliance News) - Fusion Antibodies PLC on Monday said its loss has widened and revenue is down, after the first half of the financial year proved a "...